13F Holdings
中文EN

RDGT Ridgetech Inc. Annual reports only

Retail-Drug Stores and Proprietary Stores · Nasdaq · SEC CIK 1856084 · Fiscal year ends 03/31

Financial factors as of 2026-03-31 (FY2026), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY10.2%
TTM net income YoY-112.3%
TTM EPS YoY-106.2%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR—

Margins

Gross margin3.6%
Operating margin-1.4%
Net margin-0.9%
FCF margin-1.1%
EBITDA margin-1.1%

Returns

ROE-3.6%
ROA-1.9%
ROIC (approx.)-7.4%
Asset turnover1.98x

Leverage & solvency

Liabilities / assets40.9%
Debt / equity0.00x
Current ratio2.31x
Interest coverage-27.82x

Cash quality & payout

Operating cash flow / net income1.11x
Accruals ratio0.2%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20262026-03-31FY20252025-03-31FY20242024-03-31FY20232023-03-31FY20222022-03-31
Income statement
Revenue$132.16M$119.97M$123.99M$120.20M$164.39M
Cost of revenue$127.41M$116.13M$119.12M$116.60M$127.87M
Gross profit$4.75M$3.84M$4.88M$3.60M$36.52M
SG&A expense$3.58M$3.34M$3.35M$5.14M$8.19M
Operating income-$1.87M-$1.04M$596,082-$13.16M-$2.69M
Interest expense$67,069-$92,834-$197,763-$31,582$262,218
Pretax income-$1.35M-$950,660-$827,069-$15.44M-$2.10M
Income tax-$99,098$503,524-$41,363$394,541$1.10M
Net income-$1.25M$10.19M-$4.23M-$21.14M-$3.19M
EBITDA-$1.50M$101,901$1.39M-$12.44M-$1.44M
EPS (basic)-17.21275.87-439.78-41.46-18.35
EPS (diluted)-17.21275.87-439.78-41.46-18.35
Weighted avg. shares (diluted)72,66836,9549,628509,828173,966
Banking
Net interest income——$516,637$883,908$401,921
Deposits——$32.25M$31.56M$35.28M
Balance sheet
Cash & equivalents$17.91M$12.78M$32.87M$31.57M$35.34M
Receivables$32.47M$27.81M$6.01M$14.12M$16.74M
Inventory$8.26M$9.76M$9.08M$15.31M$16.02M
Current assets$64.56M$59.71M$69.68M$64.48M$75.36M
PP&E, net$5,723$8,931$8,377$5.10M$5.92M
Goodwill$1.46M$1.46M———
Intangibles$3.00M$3.30M$1.28M$3.20M$3.55M
Total assets$69.03M$64.48M$95.06M$90.97M$106.38M
Current liabilities$27.89M$34.36M$74.36M$66.54M$74.45M
Short-term debt——$276,997——
Total liabilities$28.25M$34.85M$80.76M$74.30M$83.65M
Shareholders' equity$40.78M$29.64M$15.64M$18.01M$24.09M
Shares outstanding887,27139,0331.74M1.18M3.48M
Cash flow statement
Operating cash flow-$1.39M$1.25M-$3.16M-$3.28M-$5.39M
Capital expenditure$449$155,360$330,677$118,272$89,960
Free cash flow-$1.39M$1.09M-$3.49M-$3.40M-$5.48M
Investing cash flow-$449-$18.14M-$2.04M-$316,097-$306,138
Financing cash flow-$29,714$1.51M$8.00M$2.37M$4.84M
Depreciation & amortization$363,686$1.14M$790,449$718,002$1.26M
Stock-based compensation———$10.36M—

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.